3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
1
Pathologic Complete Response
1
Neoplasms
1
Hemangiosarcoma
1
Breast Neoplasms
1
Interventions
pertuzumab
3
Trastuzumab
3
Docetaxel
2
tucatinib
1
atezolizumab
1
Paclitaxel
1
Neoadjuvant Therapy
1
Genetic Testing
1
Capecitabine
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
HER2-positive Breast Cancer
×
ARX788
×
30 days
×
Clear all
No trials found.